Navigation Links
Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus
Date:11/9/2010

for at least 5 and 28 days, respectively, prior to first study drug infusion. Primary endpoint was responder rate on a combined index of clinical disease activity at week 12 (defined as reduction of all baseline (BL) BILAG 2004 A to B/C/D and BL BILAG B to C/D, no BILAG worsening in other organ systems, and no deterioration in SLEDAI or physician global assessment [VAS]), with no CS, IS and antimalarials increase over BL dose. The study was not powered to detect statistical differences between treatment arms.

By week 12 (see table) combined responder index rates were higher in all epratuzumab groups than in the placebo group, reaching statistical significance in the epratuzumab 600mg weekly group (2400mg cumulative) and the combined group of all 74 patients who received a cumulative dose of 2400mg (600mg weekly and 1200mg every other week).Dose regimenPBO
(n=38)Emab cd
200mgEmab cd
800mgEmab cd 2400mgEmab cd
3600mg100mg
EOW
(n=39)400mg
EOW
(n=38)600mg
weekly
(n=37(a))1200mg
EOW
(n=37)Combined
group
(n=74)1800mg
EOW
(n=38)Responders n (%)

8 (21.1)

12 (30.8)

10 (26.3)

17 (45.9)

15 (40.5)

32 (43.2)

9 (23.7)Odds ratio1.7

(0.6-4.7)

1.3

(0.5-3.9)

3.2

(1.1-8.8)

P=0.03(b)

2.6

(0.9-7.1)

P=0.07 (b)

2.9

(1.2-7.1) p=0.02 (b)

1.2

(0.4-3.4)Table - Combined responder index, week 12 (ITT population)Emab = epratuzumab

(a) 2 patients randomized but never received drug

(b) p values not adjusted for multiple comparisonsAdditionally, by Week 12, more patients in the epratuzumab 600mg weekly group, compared with placebo, had an improvement from BILAG A/B to BILAG D in the 6 body systems, indicating no
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
(Date:8/21/2014)... 21, 2014 BreedIT Corp., ... the exclusive worldwide license holder and distributor of ... and researchers, today is pleased to announce the ... Seach Ltd, a leading Israeli medical Cannabis breeder. ... develop new breeds of medical Cannabis to meet ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
... How Each Tooth Signals the Next to Start GrowingROCHESTER, ... forces determines why mammals develop a single row of ... published today in the journal Science. When completely understood, ... guide efforts to re-grow missing teeth and prevent cleft ...
... preventing bone loss focus on early screening and treatmentLAS ... 75 million baby boomers are approaching the age where ... Osteoporosis ( http://orthoinfo.aaos.org/topic.cfm?topic=A00232 ) also contributes ... United States annually. According to new information presented ...
Cached Medicine Technology:Scientists Discover Why Teeth Form in a Single Row 2Scientists Discover Why Teeth Form in a Single Row 3Scientists Discover Why Teeth Form in a Single Row 4Scientists Discover Why Teeth Form in a Single Row 5Staying One Step Ahead of Osteoporosis 2Staying One Step Ahead of Osteoporosis 3Staying One Step Ahead of Osteoporosis 4
(Date:8/21/2014)... The American College of Chest Physicians (CHEST) announces ... Ill and Injured During Pandemics and Disasters: CHEST ... of the journal CHEST while the ... Ebola virus. The consensus statement aims to guide ... research in crises. The statement was developed by ...
(Date:8/21/2014)... Hudson County, NJ (PRWEB) August 21, 2014 ... that two leading Radiologists, Amish P. Patel, MD, ... Department. Our system welcomes Dr. Patel and Dr. ... provides a comprehensive array of diagnostic imaging services ... resources of Bayonne Medical Center, Christ Hospital and ...
(Date:8/21/2014)... with schizophrenia often have trouble engaging in daily tasks ... from San Francisco State University suggests the reason might ... required to complete tasks. , The research, detailed in ... of Abnormal Psychology , can assist health professionals in ... those patients function normally by breaking up larger, complex ...
(Date:8/21/2014)... 2014 Greater awareness among parents and ... before they are full term has decreased the practice ... the country, early elective deliveries (EEDs) still occur too ... EED is defined as delivery before 39 weeks without ... morbidity and mortality, and offers no benefit to mothers ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Black Americans are ... racial groups battling the blood sugar disease, a new ... National Health and Nutrition Examination Survey, which evaluates about ... the highest rates of a condition known as diabetic ... blindness in people with diabetes. Diabetic macular edema ...
Breaking Medicine News(10 mins):Health News:CHEST releases new expert guidance in care of the critically ill and injured 2Health News:Two Top Radiologists Join CarePoint Health 2Health News:Difficulty assessing effort drives motivation deficits in schizophrenia, study finds 2Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 2Health News:New “Playbook” Aims to Eliminate Early Elective Deliveries in the United States 3Health News:Blacks May Face Higher Risk of Diabetes-Linked Vision Loss 2
... Authentidate Holding Corp. (Nasdaq: ADAT ), ... management services, today announced that it plans to report financial ... 2009 on Monday, November 16, 2009, after the close of ... Monday, November 16, 2009, at 4:30 p.m. ET, to discuss ...
... ... By Focusing On Each Person,s Spiritual Potential and How It Affects Relationships, Career and ... ... and president of Spiritual Personality, has just announced an innovative system to categorize personality. ...
... It is ... of help, unaware of their rights, if Yaz, the most popular birth control pill in the ... to women or the families of women who have suffered from serious health problems after taking ... St. Louis, MO (Vocus) November ...
... , INDIANAPOLIS, Nov. 12 Centerplate, the ... and sports stadiums, announced today with the Capital ... comprehensive investigation of Lucas Oil Stadium to immediately ... the facility operates as a model of operational ...
... (OTC Bulletin Board: VIVK) is the keynote presenting company ... International, Inc. ( www.regeneca.com ). The celebration ... of Regeneca International from across the United States. It ... in Newport Beach, California. Vivakor,s Chairman, Matt Nicosia ...
... Peak Performance Symposium will take place on November 16th ... Stazione Centrale), Milan Central Station. , http://www.mindroom.com/detailinside.php?id=1 ... the benefits that the application of Neuroscience Research can ... Business. Modern approaches of Neurofeedback and Biofeedback will be ...
Cached Medicine News:Health News:Authentidate Holding Corp. to Report Fiscal 2010 First Quarter Results on Monday, November 16, 2009 2Health News:Hawaii Psychiatrist Develops Radical New System of Understanding and Categorizing Personality 2Health News:Yaz and Yasmin Birth Control Lawsuits Continue to Mount,The Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side Effects 2Health News:Yaz and Yasmin Birth Control Lawsuits Continue to Mount,The Onder Law Firm Will Provide a Free Case Review to Women Suffering from Yaz Side Effects 3Health News:Centerplate and the Capital Improvement Board Investigating Food Safety Violations at Lucas Oil Stadium to Ensure Highest Standards Achieved and Operational Excellence 2Health News:Vivakor Presents at Nutraceutical Event 2Health News:Vivakor Presents at Nutraceutical Event 3Health News:Vivakor Presents at Nutraceutical Event 4Health News:Vivakor Presents at Nutraceutical Event 5Health News:Vivakor Presents at Nutraceutical Event 6Health News:Peak Performance, Neurofeedback and Biofeedback: New Frontiers of Empowerment From, and In, Sport 2
... five classes of resectoscope electrodes for ... knife, roller bar & ball, and ... electrodes specifically integrated into the ACMI ... with minimal bleeding, increased visibility, and ...
... Pro System features a small diameter Percutaneous ... With a reduced outer diameter (11Fr.) and ... can be used as a nephroscope or ... an outer sheath (15.9Fr), it can be ...
ACMI™ S-Series Resectoscope Systems: Precision instruments designed for superior optical recognition, accurate control, and exceptional durability during steam autoclave sterilization....
... Rotating Continuous Flow Resectoscopes enhance ease of ... the working element and telescope to the ... result no rotating components in the ... rotating flow ports, simplifying procedures. The new ...
Medicine Products: